CD34 expression in primary cutaneous malignant melanoma: Apropos of a case and review of the aberrant melanoma phenotype

Journal of Cutaneous Pathology

Volumn 32, Issue 10, 2005, Pages 685-689

  Breza, Thomas S ^a   Magro, Cynthia M ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HMB 45 ANTIGEN; MELAN A; PROTEIN S 100; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AGED; AMELANOTIC MELANOMA; ANTIGEN EXPRESSION; BLUE NEVUS; BONE MARROW CELL; CASE REPORT; DERMATOFIBROSARCOMA PROTUBERANS; ENDOTHELIUM CELL; EXCISION; FEMALE; HETEROCHROMATIN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MELANOMA; PHENOTYPE; REVIEW; SENTINEL LYMPH NODE BIOPSY; SPINDLE CELL CARCINOMA; UVEA MELANOMA;

AGED, 80 AND OVER; ANTIGENS, CD34; ANTIGENS, NEOPLASM; FEMALE; HUMANS; IMMUNOPHENOTYPING; MELANOMA; NEOPLASM PROTEINS; S100 PROTEINS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 28344438314     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2005.00367.x     Document Type: Review

References (30)

1. Sheffield M, Yee H, Dorvault C, et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol 2002; 118: 930.
2. Nakajima T, Watanabe S, Sato Y, Kameya T, Hirota T, Shimosato Y. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol 1982; 6: 715.
3. Hofbauer G, Kamarashev J, Geertsen R, Boni R, Dummer R. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. J Cutan Pathol 1998; 25: 204.
4. Wick M, Swanson P, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988; 15: 201.
5. Orchard GE. Comparison of immunohistochemical labeling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB-45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 2000; 32: 475.
6. Govender D, Sabaratnam R, Essa A. Clear cell 'sugar' tumor of the breast: another extrapulmonary site and review of the literature. Am J Surg Pathol 2002; 26: 670.
7. Boyle J, Haupt H, Stern J, Multhaupt H. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Arch Pathol Lab Med 2002; 126: 816.
8. Chen Y, Stockert E, Jungbluth A, et al. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 1996; 93: 5915.
9. Blessing K, Sanders D, Grant J. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998; 32: 139.
10. Aiba S, Tabata N, Ishii H, Ootani H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol 1992; 127: 79.
11. Cohen P, Rapini R, Farhood A. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. J Cutan Pathol 1993; 20: 15.
12. Molgaard H, Spurr N, Greaves M. The hemopoietic stem cell antigen, CD34, is encoded by a gene located on chromosome 1. Leukemia 1989; 3: 773.
13. Weiss S, Nickoloff B. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993; 17: 1039.
14. Nickoloff B. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 1991; 127: 523.
15. Mulvany N, Sykes P. Desmoplastic melanoma of the vulva. Pathology 1997; 29: 241.
16. Hoang M, Selim M, Bentley R, Burchette J, Shea C. CD34 expression in desmoplastic melanoma. J Cutan Pathol 2001; 28: 508.
17. Chen X, Maniotis A, Majumdar D, Pe'er J, Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci 2002; 43: 2533.
18. Smith K, Germain M, Williams J, Skelton H. CD34-positive cellular blue nevi. J Cutan Pathol 2001; 28: 145.
19. Maniotis A, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol 1999; 155: 739.
20. Hendrix M, Seftor E, Meltzer P, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 2001; 98: 8018.
21. Goncharuk V, Mulvany M, Carlson A. Bednar tumor associated with dermal melanocytosis: melanocytic colonization or neuroectodermal multidirectional differentiation? J Cutan Pathol 2003; 30: 147.
22. Banks E, Jansen J, Oberle E, Davey D. Cytokeratin positivity in fine-needle aspirates of melanomas and sarcomas. Diagn Cytopathol 1995; 12: 230.
23. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins. Lab Invest 1989; 61: 623.
24. Zarbo RJ, Gown A, Nagle R, Visscher D, Crissman J. Anomalous cytokeratin expression in malignant melanoma, one and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol 1990; 3: 494.
25. Hendrix M, Seftor E, Chu Y, et al. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. J Natl Cancer Inst 1992; 84: 165.
26. Shah IA, Gani OS, Wheler L. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi. Pathol Res Pract 1997; 193: 497.
27. Banerjee S, Bishop P, Nicholson C, Eyden B. Malignant melanoma showing smooth muscle differentiation. J Clin Pathol 1996; 49: 950.
28. Carlson J, Dickersin G, Sober A, Barnhill R. Desmoplastic neurotropic melanoma, a clinicopathologic analysis of 28 cases. Cancer 1995; 75: 478.
29. Argenyi Z, Cain C, Bromley C, et al. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study. Am J Dermatopathol 1994; 16: 233.
30. Abbott JJ, Amirkhan RH, Hoang MP. Malignant melanoma with a rhabdoid phenotype: histologic, immunohistochemical, and ultrastructural study of a case and review of the literature. Arch Pathol Lab Med 2004; 128: 686.